Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 65Neoplasms 31Small Cell Lung Carcinoma 26Carcinoma, Hepatocellular 24Melanoma 23Colorectal Neoplasms 23Triple Negative Breast Neoplasms 20Carcinoma, Renal Cell 20Carcinoma, Transitional Cell 19Breast Neoplasms 18Neoplasm Metastasis 14Urinary Bladder Neoplasms 13Stomach Neoplasms 12Uterine Cervical Neoplasms 11Solid Tumors 11Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 8Lymphoma 7Lung Neoplasms 7Lymphoma, Non-Hodgkin 6Head and Neck Neoplasms 6Esophageal Neoplasms 6Pancreatic Neoplasms 5Liver Neoplasms 5Carcinoma, Merkel Cell 5Advanced Solid Tumor 5Solid Tumor 4Prostatic Neoplasms 4Leukemia, Myeloid, Acute 4Kidney Neoplasms 4

Interventions

Gemcitabine 2valrubicin 1pembrolizumab 1liposomal doxorubicin 1fludarabine phosphate 1fludarabine 1atezolizumab 1Tumor Necrosis Factor-alpha 1Oncolytic Virotherapy 1Mitomycin 1Interferons 1Interferon-beta 1Immune Checkpoint Inhibitors 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Adenoviridae Infections × atezolizumab × Clear all
NCT02705196 2026-02-24

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Lokon Pharma AB

Phase 1/2 Completed
51 enrolled
Gastrointestinal

Adenoviridae Infections, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡